✦ LIBER ✦

Development of a Naphthyridinone P38 Kinase Inhibitor

✍ Scribed by John Y. L. Chung; Raymond J. Cvetovich

Publisher: John Wiley and Sons
Year: 2007
Weight: 11 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200724232

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

p38 MAP Kinase Inhibitors: Metabolically

p38 MAP Kinase Inhibitors: Metabolically Stabilized Piperidine-Substituted Quinolinones and Naphthyridinones.

✍ Jianming Bao; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 14 KB

Synthesis of a Naphthyridone p38 MAP Kin

Synthesis of a Naphthyridone p38 MAP Kinase Inhibitor.

✍ John Y. L. Chung; Raymond J. Cvetovich; Mark McLaughlin; Joseph Amato; Fuh-Rong 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 12 KB 👁 1 views

Imidazopyrimidines, Potent Inhibitors of

Imidazopyrimidines, Potent Inhibitors of p38 MAP Kinase.

✍ Kenneth C. Rupert; James R. Henry; John H. Dodd; Scott A. Wadsworth; Druie E. Ca 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 11 KB 👁 1 views

p38 Inhibitors: Piperidine- and 4-Aminop

p38 Inhibitors: Piperidine- and 4-Aminopiperidine-Substituted Naphthyridinones, Quinolinones, and Dihydroquinazolinones.

✍ Julianne A. Hunt; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 88 KB

ChemInform Abstract: Potent Inhibitors o

ChemInform Abstract: Potent Inhibitors of the MAP Kinase p38.

✍ James R. Henry; Kenneth C. Rupert; John H. Dodd; Ignatius J. Turchi; Scott A. Wa 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

Substituted Isoxazoles as Potent Inhibit

Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase

✍ Stefan A. Laufer; Simona Margutti; Martina D. Fritz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

## Abstract __In a continuous effort to develop improved p38 MAP (mitogen‐activated protein) kinase inhibitors, we focused our attention on the suitability of the isoxazole ring as a bioisosteric replacement for the imidazole ring of SB‐203580. 3,4‐ and 4,5‐disubstituted as well as 3,4,5‐trisubstit